This inventor holds 1 USPTO granted patent. Top assignee: Ichnos Sciences Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Dyson and His Patent in Antibody Innovation.
Introduction
Michael Dyson is an inventor based in Neuchâtel, Switzerland. His patent work includes a trispecific antibody invention associated with Ichnos Sciences SA.
Latest Patents
Dyson is listed as an inventor on one patent: CD3/BCMA/CD38 Trispecific Antibodies. The invention concerns antibodies designed to target CD3, BCMA, and CD38.
Career Highlights
Dyson’s recorded patent activity includes 1 patent. The available information connects his work with Ichnos Sciences SA.
Collaborations
His listed coworkers include Maria Pihlgren Bosch and Mario Perro.
Conclusion
Michael Dyson’s patent record highlights his contribution to trispecific antibody innovation through work associated with Ichnos Sciences SA.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile